CTXR Cash Flow Breakdown | Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Citius Pharmaceuticals, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

Fiscal year ended 2025-12-31: from running the business, $34.84M went out.
Fiscal year ended 2025-12-31: from financing, $51.61M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year end	Running the business	From investing	Debt paid back	New debt	New shares sold	Not split out	Change in cash
2025-12-31	-$34.84M*				$50.61M*	$1.00M*
2025-09-30	-$26.55M	-$5.75M			$32.30M	$1.00M*	$1.00M
2024-12-31	-$26.79M*
2024-09-30	-$28.20M	-$5.00M			$13.80M	-$3.83M*	-$23.23M
2023-12-31	-$30.37M*
2023-09-30	-$29.06M				$31.27K	$13.80M*	-$15.23M
2022-12-31	-$28.53M*
2022-09-30	-$28.36M						-$28.36M
2021-12-31	-$19.34M*
2021-09-30	-$24.25M	-$40.01M			$500.00	$120.47M*	$56.21M
2020-12-31	-$21.38M*					$22.90M*
2020-09-30	-$16.93M	-$1.83K				$22.90M*	$5.97M
2019-12-31	-$15.39M*					$11.13M*	-$4.26M*
2019-09-30	-$12.44M					$11.15M*	-$1.29M
2018-12-31	-$11.04M*					$10.71M*	-$329.22K*
2018-09-30	-$11.32M					$17.30M*	$5.98M
2017-12-31	-$9.10M*					$16.42M*	$7.32M*
2017-09-30	-$7.97M	-$2.13K			$40.00	$10.88M*	$2.91M
2016-12-31	-$6.52M*					$6.03M*	-$234.72K*
2016-09-30	-$5.90M	$255.75K		$10.00M		-$4.74M*	-$381.79K
2015-12-31	-$2.35M*						-$535.75K*
2015-09-30	-$2.39M					$1.51M*	-$875.92K
2014-12-31	-$396.11K*						$709.73K*
2014-09-30	-$183.16K				$50.00K	$1.63M*	$1.50M
2013-12-31	-$1.10M	$0.00*		$33.62K*	$0.00*	$1.07M*	$12.73K
2013-09-30	-$20.60K	$0.00	-$30.15K	$16.30K	$0.00		-$135.00
2012-12-31	-$917.80K	-$2.02K		$17.25K*	$500.00K		-$19.82K
2012-09-30	-$20.32K	$0.00	$0.00	$17.05K	$0.00		-$77.00
2011-12-31	-$19.94K*	$0.00*					-$743.00*
2011-09-30	-$20.78K	$0.00		$0.00	$0.00		-$2.29K

Each quarter (3 month)

Quarter end	Running the business	From investing	Debt paid back	New debt	New shares sold	Not split out	Change in cash
2026-06-30	-$8.68M*	-$2.00M*			$4.45M*	$18.64M*
2026-03-31	-$1.30M*	-$600.00K*			-$62.76K*	-$1.17M*
2025-12-31	-$13.01M	-$4.40M			$20.88M		$3.47M
2025-09-30	-$11.88M*				$15.79M*
2025-06-30	-$5.41M*				$10.47M*	$1.00M*
2025-03-31	-$4.54M*				$3.47M*
2024-12-31	-$4.73M				$2.57M		-$2.15M
2024-09-30	-$5.91M*				$84.73K*	-$3.83M*
2024-06-30	-$8.37M*
2024-03-31	-$7.79M*
2023-12-31	-$6.14M						-$6.14M
2023-09-30	-$6.80M*				$0.00*
2023-06-30	-$9.58M*				$0.00*	$13.80M*
2023-03-31	-$7.85M*
2022-12-31	-$4.82M						-$4.82M
2022-09-30	-$6.33M*
2022-06-30	-$7.71M*
2022-03-31	-$9.67M*
2021-12-31	-$4.65M						-$4.65M
2021-09-30	-$5.59M*	-$40.00M*			$0.00*
2021-06-30	-$4.82M*				$0.00*	$16.80M*
2021-03-31	-$4.27M*				$0.00*	$103.67M*
2020-12-31	-$9.56M				$500.00		-$9.56M
2020-09-30	-$3.36M*	$0.00*				$8.70M*
2020-06-30	-$3.99M*					$8.17M*
2020-03-31	-$4.47M*					$6.03M*	$1.56M*
2019-12-31	-$5.11M						-$5.11M
2019-09-30	-$2.91M*					$6.29M*	$3.38M*
2019-06-30	-$3.52M*					$4.83M*	$1.31M*
2019-03-31	-$3.85M*						-$3.84M*
2018-12-31	-$2.16M						-$2.14M
2018-09-30	-$2.50M*					$8.93M*	$6.42M*
2018-06-30	-$2.25M*						-$2.25M*
2018-03-31	-$4.13M*					$1.76M*	-$2.36M*
2017-12-31	-$2.44M					$6.61M*	$4.17M
2017-09-30	-$3.43M*				$0.00*	$6.44M*	$3.01M*
2017-06-30	-$2.40M*					$2.54M*	$137.62K*
2017-03-31	-$824.60K*					$838.95K*	$14.35K*
2016-12-31	-$1.31M					$1.07M*	-$247.59K
2016-09-30	-$1.77M*	$0.00*					-$1.33M*
2016-06-30	-$2.56M*	$0.00*					-$2.13M*
2016-03-31	-$874.45K*					$4.10M*	$3.48M*
2015-12-31	-$697.09K						-$394.65K
2015-09-30	-$705.30K*						-$274.86K*
2015-06-30	-$628.41K*					$819.05K*	$190.64K*
2015-03-31	-$316.88K*						-$56.88K*
2014-12-31	-$734.82K						-$734.82K
2014-09-30	$419.67K*				$0.00*	$1.06M*	$1.48M*
2014-06-30	-$48.48K*	$0.00*		$4.99K*	$50.00K*		$1.51K*
2014-03-31	-$32.46K*	$0.00*	$0.00*	$3.48K*	$0.00*		-$32.46K*
2013-12-31	-$521.88K	$0.00	$0.00	$17.52K	$0.00	$557.48K*	$53.12K
2013-09-30	-$7.40K*	$0.00*		$3.20K*	$0.00*		-$27.00*
2013-06-30	-$3.24K*	$0.00*		$13.10K*	$0.00*		-$36.00*
2013-03-31	-$9.74K*	$0.00*	$0.00*	-$200.00*	$0.00*		-$36.00*
2012-12-31	-$236.00	$0.00	$0.00	$200.00	$0.00		-$36.00
2012-09-30	-$5.45K*	$0.00*		$14.11K*	$0.00*		-$36.00*
2012-06-30	-$5.98K*	$0.00*		$2.94K*	$0.00*		$154.00*
2012-03-31	-$6.70K*	$0.00*		$0.00*	$0.00*		-$199.00*
2011-12-31	-$2.20K	$0.00		$0.00	$0.00		$4.00
2011-09-30	-$4.94K*	$0.00*					$147.00*
2011-06-30	-$5.14K*	$0.00*					$65.00*
2011-03-31	-$7.65K*	$0.00*					-$959.00*
2010-12-31	-$3.04K	$0.00					-$1.54K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Korsana Biosciences, Inc. (CYCN)	United States	$0.016B
Lantern Pharma Inc. (LTRN)	United States	$0.015B	-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)	United States	$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)	United States	$0.015B
Pasithea Therapeutics Corp. (KTTA)	United States	$0.017B	-0.81
Tvardi Therapeutics, Inc. (TVRD)	United States	$0.014B
Vyome Holdings, Inc (HIND)	United States	$0.014B	-1.38
Allarity Therapeutics, Inc. (ALLR)	United States	$0.017B	-1.66
BullFrog AI Holdings, Inc. (BFRG)	United States	$0.014B
PALATIN TECHNOLOGIES INC (PTN)	United States	$0.017B	-5.36